Fosun Pharma
↗Shanghai, China
Founded in 1994, Fosun Pharma is a leading global innovation-driven healthcare group deep-rooted in China. The company operates across the entire healthcare value chain, including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services (hospitals). It is particularly known for its strategic '4IN' strategy: Innovation, Internationalization, Intelligentization, and Integration.
Fosun Pharma is a dominant player in the Chinese market and has established a significant global footprint through subsidiaries like Henlius (biologics), Gland Pharma (injectables), and Sisram Medical (energy-based devices). The company is a key partner for global giants, notably collaborating with BioNTech to bring the first mRNA COVID-19 vaccine to the Greater China region and with Kite Pharma for CAR-T cell therapies.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Biotechnology and Medical Devices
SIZE & FINANCIALS
Employees:10000+
Revenue:$5.7B (2024)
Founded:1994
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:Fosun High Technology (Controlling Shareholder), Institutional investors via public markets
STOCK
Exchange:SSE; HKEX
Ticker:600196.SH; 02196.HK
Market Cap:~$9.3B USD
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, mAb, ADC, Cell therapy (CAR-T), RNA therapeutics, Vaccines
Active Trials:80
Trial Phases:Phase 1: 25 | Phase 2: 30 | Phase 3: 15 | Phase 4: 10
FDA Approvals:5
EMA Approvals:4
CORPORATE STRUCTURE
Parent Company:Fosun International Limited
Subsidiaries:Shanghai Henlius Biotech, Gland Pharma, Sisram Medical, Fosun Kairos (formerly Fosun Kite), Wanbang Pharma, Guilin Pharma
Key Partnerships:BioNTech (mRNA Vaccines), Kite Pharma (Cell Therapy), Intuitive Surgical (Da Vinci Robots), Sinopharm (Distribution), Saudi Arabia Fakeeh Care Group (Commercialization)
COMPETITION
Position:Leader
Competitors:Hengrui Medicine, BeiGene, Sino Biopharmaceutical, Innovent Biologics
LEADERSHIP
Key Executives:
Chen Yuqing - Chairman
Liu Yi - CEO & President
Scientific Founders:Guo Guangchang
Board Members:Guan Xiaohui (Co-Chairman), Wen Deyong (Vice Chairman), Chen Qiyu, Wu Yifang
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Fosun Pharma. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.